Opaleye Management Inc. - Aug 4, 2021 Form 4 Insider Report for Eton Pharmaceuticals, Inc. (ETON)

Role
10%+ Owner
Signature
Opaleye Management Inc., By: /s/ James Silverman, President
Stock symbol
ETON
Transactions as of
Aug 4, 2021
Transactions value $
-$3,523,187
Form type
4
Date filed
8/6/2021, 09:53 PM
Previous filing
Jul 22, 2021
Next filing
Aug 19, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETON Common Stock, par value $0.001 per share Sale -$575K -100K -2.82% $5.75 3.45M Aug 4, 2021 By Opaleye, L.P. F1, F3
transaction ETON Common Stock, par value $0.001 per share Sale -$23K -4K -2.82% $5.75 138K Aug 4, 2021 By Managed Account F2, F3
transaction ETON Common Stock, par value $0.001 per share Sale -$878K -150K -4.35% $5.85 3.3M Aug 5, 2021 By Opaleye, L.P. F1, F4
transaction ETON Common Stock, par value $0.001 per share Sale -$32.2K -5.5K -4% $5.85 132K Aug 5, 2021 By Managed Account F2, F4
transaction ETON Common Stock, par value $0.001 per share Sale -$1.93M -330K -10% $5.84 2.97M Aug 6, 2021 By Opaleye, L.P. F1, F5
transaction ETON Common Stock, par value $0.001 per share Sale -$87.6K -15K -11.36% $5.84 117K Aug 6, 2021 By Managed Account F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents securities owned directly by Opaleye, L.P. (the "Fund"). As the investment manager of the Fund, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Fund.
F2 Securities owned by a separately managed account (the "Managed Account"). As the portfolio manager of the Managed Account, Opaleye Management Inc. may be deemed to beneficially own the securities owned directly by the Managed Account
F3 The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $5.7514. The range of sale prices on the transaction date was $5.60 to $5.98 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
F4 The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $5.8532. The range of sale prices on the transaction date was $5.53 to $6.04 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
F5 The common stock was sold by the reporting person in open market transactions on the transaction date, with a volume weighted average sale price of $5.8402. The range of sale prices on the transaction date was $5.65 to $6.3750 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.